SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VICL (Vical Labs)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
1972 55 0 VICL
Emcee:  bob clark Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1872GS Vical Inc. EPS (FY Dec) 2006E ($0.92), 2007E ($1.02) Underperform/Neutral (Vbob zagorin-4/7/2006
1871Gene Therapy Used To Successfully Treat 2 Patients By GAUTAM NAIK April 3, 2006;bob zagorin-4/3/2006
1870proxy for annual meeting.. xml.10kwizard.combob zagorin-4/3/2006
1869Another Insider Buy today - again, an entire 500 shares, but the CEO paid $6.18 Rutgers-4/3/2006
1868Another Insider Buy on Friday - only 500 shares, but the CFO paid $6.16 for themRutgers-4/1/2006
1867Coverage Initiated Company Ticker Brokerage Firm Ratings Change Price Targebob zagorin-3/31/2006
1866Vical's DNA Vaccine With Vaxfectin(TM) Adjuvant Advances in Pandemic InfluenRutgers-3/31/2006
1865Recommendation Changes Symbol Broker Change From To Date VICL Majorbob zagorin-3/23/2006
1864Vical Licensee Sanofi-Aventis Releases Phase 2b Angiogenesis Data and Plans for nigel bates-3/13/2006
186310k xml.10kwizard.combob zagorin-3/10/2006
1862U.S. Approves Development Of Second Bird-Flu Vaccine Associated Press March 6, 2bob zagorin-3/7/2006
1861whoopee. vj just bot 500 shares on open market.. sec.govbob zagorin-3/2/2006
1860Vical Announces Webcast of CEO Presentation at Cowen & Co. Health Care Confebob zagorin-2/28/2006
1859from zacks EPS Estimate Revisions Symbol Broker Revision Period Period End bob zagorin-2/24/2006
1858Alnylam shares gain on Novartis deal Avian-flu stocks move broadly higher By Valbob zagorin-2/22/2006
1857Ebola DNA Vaccine Produces Immune Responses in All Fully Vaccinated Volunteers ibob zagorin-2/21/2006
1856GS on VICL Vical Inc. EPS (FY Dec) 2006E ($0.92), 2007E ($1.02) Underperform/Nebob zagorin-2/15/2006
1855Vical Reports 2005 Financial Results Tuesday February 14, 7:30 am ET SAN DIEGO,bob zagorin-2/14/2006
1854xml.10kwizard.combob zagorin-2/7/2006
1853Vical Announces News Release and Conference Call Schedule for 2005 Financial Resbob zagorin-2/7/2006
1852xml.10kwizard.combob zagorin-2/6/2006
1851Scientists Develop Faster Process To Produce Vaccine for Bird Flu By BETSY MCKAYbob zagorin-2/2/2006
1850Vical Opens Phase 2 Trial of DNA Vaccine Against CMV Wednesday February 1, 7:30 bob zagorin-2/1/2006
1849Vical Files $70 Million Shelf Registration Friday January 27, 7:30 am ET SAN DIbob zagorin-1/27/2006
1848Vical Licenses Core Technology to Stanford, Harvard and Yale 1/24/2006 7:30:35 Abob zagorin-1/24/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News